Phase 3 Glomerulonephritis Clinical Trials
6 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–6 of 6 trials
Recruiting
Phase 3
Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN
C3 GlomerulopathyImmune-complex-membranoproliferative Glomerulonephritis
Novartis Pharmaceuticals225 enrolled50 locationsNCT03955445
Recruiting
Phase 3
Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
Kidney DiseasesKidney Diseases, ChronicUrological Diseases+5 more
Novartis Pharmaceuticals220 enrolled6 locationsNCT06858319
Recruiting
Phase 3
Clinical Study of Rituximab for the Treatment for Idiopathic Membranous Nephropathy with Nephrotic Syndrome
Nephrotic Syndrome，IdiopathicGlomerulonephritis, Membranous
Shoichi Maruyama MD PhD88 enrolled18 locationsNCT05914155
Recruiting
Phase 3
Efficacy of Immunosuppressive Therapy for IgA Nephropathy With Stage 3 or 4 CKD
Glomerulonephritis, IGA
Air Force Military Medical University, China208 enrolled1 locationNCT05510323
Completed
Phase 3Phase 4
Fiji Northern Division Ivermectin Mass Drug Administration for Scabies Trial
Post streptococcal glomerulonephritisInvasive group A streptococcal infectionsSkin and soft tissue infections+3 more
Murdoch Children's Research Insititute135,000 enrolled1 locationACTRN12618000461291
Recruiting
Phase 2Phase 3
Evaluation of Captopril and Nifedipine in Treatment of Hypertension in Children with Post-streptoccal Acute Glomerulonephritis with Hypertension- A Randomized Control Trial
Control of Blood Pressure in Patients with Post-sterptococcal Acute Glomerulonephritis (PSAGN)Renal profiles in patients with Post-streptococcal Acute Glomerulonephritis (PSAGN)
Universiti Sains Malaysia (USM)40 enrolled1 locationACTRN12611000778987